ATAI · ISSUER CIK 2081043
AtaiBeckley Inc.
Between Aug 1, 2026 and Oct 29, 2026, 8 AtaiBeckley Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗8 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 11, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 202617:44 | Sep 11, 2026 | ATAI | Chief Medical Officer | D · To issuer | — | −8,437 | 0 | -100% | — | ||
| Sep 11, 202617:44 | Sep 11, 2026 | ATAI | Chief Accounting Officer | D · To issuer | — | −140,045 | 0 | -100% | — | ||
| Sep 11, 202617:44 | Sep 11, 2026 | ATAI | See remarks | D · To issuer | — | −155,066 | 0 | -100% | — | ||
| Sep 11, 202617:44 | Sep 11, 2026 | ATAI | Chief Scientific Officer | D · To issuer | — | −42,333 | 0 | -100% | — | ||
| Sep 11, 202617:44 | Sep 11, 2026 | ATAI | Director | D · To issuer | — | −4,666 | 0 | -100% | — | ||
| Sep 11, 202617:44 | Sep 11, 2026 | ATAI | Director | D · To issuer | — | −4,666 | 0 | -100% | — | ||
| Sep 11, 202617:44 | Sep 11, 2026 | ATAI | See remarks, Director | D · To issuer | — | −216,442 | 0 | -100% | — | ||
| Sep 11, 202617:44 | Sep 11, 2026 | ATAI | Director, 10% Owner · +1 joint | D · To issuer | — | −55,756,748 | 0 | -100% | — |